| Date | Time | Source | Headline | Symbol | Company |
| 04/28/2009 | 4:03PM | Dow Jones News | Amylin Proxy Battle Adds To Debate Over What Makes A 'Group' | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 04/24/2009 | 4:06PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/24/2009 | 3:24PM | Business Wire | Eastbourne Capital Comments on Recent Developments Regarding Amylin Pharmaceuticals | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/24/2009 | 3:00PM | Edgar (US Regulatory) | Proxy Soliciting Materials (revised) (PRRN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/24/2009 | 8:02AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/24/2009 | 6:02AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/24/2009 | 5:47AM | Dow Jones News | UPDATE: Novo Nordisk Has Big Hopes For EU Victoza Launch | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 04/23/2009 | 9:13PM | PR Newswire (US) | Amylin Issues Statement in Response to Carl Icahn | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/23/2009 | 4:43PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/23/2009 | 3:19PM | PR Newswire (US) | Icahn Asks Amylin to Allow Discussions With Eastbourne | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/23/2009 | 6:00AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/22/2009 | 5:32PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/22/2009 | 5:30PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/22/2009 | 5:17PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/21/2009 | 4:58PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/21/2009 | 4:57PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials - Non-Management (definitive) (DFAN14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/21/2009 | 4:07PM | PR Newswire (US) | Icahn Responds to Cook and Wilson | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/20/2009 | 3:11PM | PR Newswire (US) | Icahn to Respond to Amylin Letter | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/20/2009 | 3:01PM | Dow Jones News | UPDATE: US Drug Stocks Flee Into Negative Territory | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 04/20/2009 | 11:28AM | Dow Jones News | 2nd UPDATE: Eli Lilly 1Q Net Up 23%, Tops Views; Margins Rise | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 04/20/2009 | 10:55AM | Dow Jones News | Drug Stocks, Broader Market Slide Due To Economic Fears | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 04/20/2009 | 8:02AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/20/2009 | 8:00AM | Edgar (US Regulatory) | Proxy Statment - Contested Solicitations (definitive) (DEFC14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/17/2009 | 5:15PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/16/2009 | 5:10PM | Dow Jones News | Amylin Pharma 1Q Loss Narrows; Co Reiterates Focus On Byetta | NASDAQ:AMLN | Amylin Pharmaceuticals Inc. |
| 04/16/2009 | 4:35PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/16/2009 | 4:33PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/16/2009 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports First Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/15/2009 | 5:15PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/15/2009 | 5:12PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |